~~<i id='C2FA4BC453'><strike id='C2FA4BC453'><tt id='C2FA4BC453'><pre id='C2FA4BC453'></pre></tt></strike></i>~~

Home» Wikipedia» knowledge

knowledge

author：fashion 2025-09-30 09:47:37 Page View：22

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Microbiome research is starting to find links to chronic diseases
Next article： After affirmative action ruling, medical educators look to 'holistic review'

leisure time

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

It's been 20 years since Dolly the sheep. Where's my clone?

AlexHogan/STAT,GettyImagesDolly,thefirstanimaltobeclonedfromanadultofitsspecies,wasborn20yearsagotod

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport